quinazolines has been researched along with gsk525762a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Günther, S; Lucas, X | 1 |
| Papavassiliou, AG; Papavassiliou, KA | 1 |
| Dang, CV; Gao, S; Gurung, B; Hua, X; Jin, G; Katona, BW; Kong, XC; Liao, J; Matkar, S; Muhammad, AB; Sharma, P; Wang, L | 1 |
3 other study(ies) available for quinazolines and gsk525762a
| Article | Year |
|---|---|
Targeting the BET family for the treatment of leukemia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azepines; Benzodiazepines; Cell Cycle Proteins; Cell Proliferation; Gene Expression; Humans; Leukemia; Nuclear Proteins; Protein Serine-Threonine Kinases; Quinazolines; Quinazolinones; RNA-Binding Proteins; Transcription Factors; Triazoles | 2014 |
Bromodomains: pockets with therapeutic potential.
Topics: Benzodiazepines; Binding Sites; Clinical Trials as Topic; Humans; Molecular Targeted Therapy; Protein Binding; Protein Interaction Domains and Motifs; Quinazolines; Quinazolinones; Small Molecule Libraries | 2014 |
An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis.
Topics: Animals; Benzodiazepines; Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Synergism; Epigenesis, Genetic; Female; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mice; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Quinazolines; Receptor, ErbB-2; Xenograft Model Antitumor Assays | 2015 |